Vyvanse yekurapa ADHD muvana

Vyvanse inorwisa mushonga weDHD . Iyo FDA inogamuchirwa uye inowanikwa kubvira muna July 2007.

Vyvanse ye ADHD

Vyvanse inorapwa-kamwe-ye-zuva kuvanhu vakuru nevana vane makore matanhatu kusvika kune gumi nemaviri vane ADHD.

Kusiyana nezvimwe zvinokurudzira, Vyvanse anofanira kupinda mudumbu uye ombwa asati agona kushanda. Izvozvo zvinoreva kuti hazvina kunyanya kukosha kuti Vyvanse achabatwa zvisina kunaka sezvo zvisingakwanisi kupfigwa, nezvimwewo, semamwe mishonga yeDHD.

Imwe nzira inobatsira yeVivvanse ndeyekuti inopedza maawa gumi nemaviri, asi mamwe maawa akawanda kwenguva refu anoita madhidhi anowanzopedza maawa 10 kusvika ku12.

Vyvanse Manyevero nemigumisiro Yechirwere

Migumisiro yeMvvanse yakafanana nezvimwe zvinokonzera ADHD uye inowanzobatanidza marwadzo emimba, kurutsira, kuora muviri, kuderera kwechido, kuora musoro, kusuruvara, uye kusagadzikana.

Zvinofadza, migumisiro yemigumisiro-kunyanya kudya kudya-inoita seichikurumidza kuderera munguva.

Kufanana nemamwe mishonga inokurudzira, Vyvanse haafaniri kushandiswa nevana vane mamiriro ezvinhu anotevera: Chirwere chemoyo kana kuoma kwemariti; kuenzanisa kusvika kune yakanyanya kuwedzera simba reropa; hyperthyroidism; glaucoma; kumusoro kwekuzvidya mwoyo, kukanganisa, kana kushungurudzika. Izvo hazvifaniriwo kushandiswa nevana vane nhoroondo yekushandisa zvinodhaka, avo vari kutora kana kutora mukati memazuva masere 14 apfuura mushonga unorwisa-depression (monoamine oxidase inhibitor kana MAOI), kana kuti avo vanofunga, vanorwara, kana aiva nemagariro kune mamwe mishonga inokurudzira.

Mwana Wako Unofanira Kuedza Vyvanse

Vyvanse inogona kuva yakanyanya kunaka kana mishonga yemwana wako ikozvino isingagumi kwenguva yakareba mukati mezuva, kana iwe unonetseka kuti mwana wako angave ari kushandisa zvisina kunaka mushonga wake.

Sources:

> Kubudirira uye kusagadzikana kwe lisdexamfetamine > dimesylate > (NRP-104) mune vana vane hanya-kushaya simba / hyperactivity disorder: chikamu chechitatu, chimiro chepamusoro, chinonzi randomized, double-blind, chibharo chakamanikidzwa, parallel-group study. Biederman J - Clin Ther - 01-MAR-2007; 29 (3): 450-63.

Vyvanse Kunyatsorondedzera Mashoko, Wayne, Pa: Shire US Inc., Revised December 2015.